Sources: Google DeepMind spinout Isomorphic Labs is in talks to raise ~$5B at a ~$50B valuation; the AI drug discovery startup last raised $2.1B in May

Significant funding could accelerate AI's impact on the pace of new drug development.

Google DeepMind spinout Isomorphic Labs is in talks to raise approximately $5 billion at a valuation of around $50 billion. The AI drug discovery startup previously raised $2.1 billion in May.

Based on limited preview — the full article may require a subscription

Isomorphic Labs, an AI drug discovery startup spun out of Google DeepMind, is in discussions to secure substantial new funding. This investment will fuel its artificial intelligence-driven approach to discovering new medicines, potentially accelerating the drug development pipeline.